A Kremers
Overview
Explore the profile of A Kremers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paulides M, Kremers A, Stohr W, Bielack S, Jurgens H, Treuner J, et al.
Pediatr Blood Cancer
. 2005 Dec;
46(4):489-95.
PMID: 16333817
Background: Prospective longitudinal examinations of anthracycline-induced cardiomyopathy in a homogeneous cohort are rare in pediatric oncology. We herein report the results of observations on the frequency of cardiomyopathy in doxorubicin-treated...
2.
Stohr W, Paulides M, Brecht I, Kremers A, Treuner J, Langer T, et al.
J Cancer Res Clin Oncol
. 2005 Oct;
132(1):35-40.
PMID: 16205946
Purpose: Up to now, cardiotoxicity of epirubicin has been studied almost exclusively in adult cancer patients. The aim of this study was to investigate epirubicin in children and adolescents, in...
3.
Stohr W, Langer T, Kremers A, Bielack S, Lamprecht-Dinnesen A, Frey E, et al.
Cancer Invest
. 2005 Jun;
23(3):201-7.
PMID: 15945505
The aim of this study was to analyze cisplatin-induced ototoxicity in a recent study trial. Seventy-four patients who had received cisplatin for the treatment of osteosarcoma (median cumulative dose: 360...
4.
Langer T, Stohr W, Paulides M, Kremers A, Dorr H, Gobel U, et al.
Klin Padiatr
. 2005 Apr;
217(3):176-81.
PMID: 15858710
Background: Late effects become progressively more important for the evaluation of therapeutic success in paediatric oncology. Thus, in 1998, the Late Effects Surveillance System (LESS) started to register and assess...
5.
Stohr W, Langer T, Kremers A, Brecht I, Treuner J, Dinnesen A, et al.
Oncol Rep
. 2004 Sep;
12(4):767-71.
PMID: 15375498
The aim of this study was to analyse carboplatin-induced ototoxicity in a recent study trial. Twenty patients who had received carboplatin for the treatment of soft tissue sarcoma were investigated...